HHS

Value 20202021202220232024 TTM Total revenue 176.9 M194.6 M206.28 M191.49 M185.24 M 166.84 M Gross profit 176.9 M194.6 M206.28 M191.49 M185.24 M 166.84 M Operating expenses 174.49 M178.04 M188.44 M178.21 M79.42 M 75.24 M Selling/general/admin expenses 21.52 M17.86 M17.97 M20.67 M22.78 M 22.26 M Research & development ————— — Operating income 10.58 M7.64 M15.11 M3.36 M2.09 M -970 K Non-Operating Income, Total 7.73 M8.62 M4.21 M5.28 M40.03 M 1.51 M Interest expense, net of interest capitalized 700 K500 K300 K200 K31 K 56 K Non-Operating Income, excl. Interest Expenses 464 K7.64 M-738 K-335 K37.66 M -400 K Unusual income/expense 6.57 M477 K4.64 M5.41 M2.33 M 1.86 M Pretax income 18.31 M16.26 M19.31 M1.92 M37.93 M 1.18 M Equity in earnings ————— — Taxes 16.61 M1.29 M17.46 M349 K7.64 M 537 K Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 1.69 M14.97 M36.78 M1.57 M30.3 M 5.16 M Discontinued operations ————— — Net income 1.69 M14.97 M36.78 M1.57 M30.3 M 5.16 M Dilution adjustment 992 K-1.77 M00— — Preferred dividends 496 K496 K1.38 M0— — Diluted net income available to common stockholders 2.19 M12.71 M35.4 M1.57 M30.3 M 5.16 M Basic earnings per share (Basic EPS) 0.341.854.98-0.21-4.15 -0.72 Diluted earnings per share (Diluted EPS) 0.341.764.75-0.21-4.15 -0.72 Average basic shares outstanding 6.47 M6.8 M7.1 M7.31 M7.29 M 29.45 M Diluted shares outstanding 6.47 M7.21 M7.46 M7.31 M7.29 M 29.45 M EBITDA 6.03 M19.12 M20.56 M17.52 M110.2 M 96.23 M EBIT 2.41 M16.56 M17.84 M13.28 M105.82 M 91.61 M Cost of revenue 00000 0 Other cost of goods sold 00000 0 Depreciation & amortization (cash flow) 3.62 M2.56 M2.73 M4.24 M4.38 M 4.62 M